C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/52 (2006.01) A61K 31/47 (2006.01) A61P 25/18 (2006.01)
Patent
CA 2575697
The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin- 3 (NK-3) receptors, such as schizophrenia.
La présente invention concerne des composés représentés par la formule (I) et leurs sels pharmaceutiquement acceptables, les compositions pharmaceutiques qui les contiennent et leur utilisation dans le traitement des maladies induites par les récepteurs de la neurokinine-2 et/ou neurokinine-3 (NK-3), telle que la schizophrénie.
Merck Sharp & Dohme Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Quinoline derivatives as neurokinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as neurokinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as neurokinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2078204